Health Inequities Seminar Series

Scientists attending a seminar in the Knight Cancer Research Building

Free webinars about the impact of health inequities

CEDAR’s Health Inequities Seminar Series aims to build awareness and advance understanding about the impact systemic health inequities have on cancer early detection and treatment though interactive talks and discussion with leaders in the field.

All are welcome. 

Let's connect

Reach out with any questions or let us know if there's a speaker you'd recommend or a topic you'd like to see discussed here. 

Our latest event:

"How to Integrate Community Structure into our Cancer Care and Why it Matters"

Robert Winn, M.D.
Robert Winn, M.D.

Presented by:

Robert Winn, M.D.
Director and Lipman Chair in Oncology, VCU Massey Cancer Center
Senior Associate Dean for Cancer Innovation and Professor of Pulmonary Disease and Critical Care Medicine, VCU School of Medicine

Wednesday, Oct. 20, 2021
1-2 p.m. PDT

In 2020, the AACR’s U.S. Cancer Disparities Progress Report showed that there is still a significant gap in cancer incidence and mortality between white Americans and other racial and ethnic groups. That’s not because the science hasn’t progressed or because people of color are biologically predisposed to cancer. It’s because the systems and structures put in place decades ago continue to harm the health of racial and ethnic minorities.

When COVID-19 hit, many of us were not surprised that communities of color were disproportionately affected. The current situation with COVID-19 vaccines is a great demonstration that while science is necessary for improving health, it’s not sufficient. Those amazingly effective vaccines can’t keep hospitals from being overwhelmed if a large percentage of the population won’t get the shot, just as advances in cancer screening and treatment can’t end disparities if
they’re predominantly going to wealthy white people.

This realization has been one of our blind spots as scientists and physicians. Not only must we work toward equitable access to care, but we must also work on building trust in medicine, which we do by demonstrating that we’re trustworthy. There’s a science to it, though we’re going to have to allow for greater flexibility and messiness than we’re accustomed to.